vs
Side-by-side financial comparison of MEDIFAST INC (MED) and OPKO HEALTH, INC. (OPK). Click either name above to swap in a different company.
OPKO HEALTH, INC. is the larger business by last-quarter revenue ($148.5M vs $75.1M, roughly 2.0× MEDIFAST INC). On growth, OPKO HEALTH, INC. posted the faster year-over-year revenue change (-19.2% vs -36.9%). MEDIFAST INC produced more free cash flow last quarter ($-6.6M vs $-28.6M). Over the past eight quarters, OPKO HEALTH, INC.'s revenue compounded faster (-7.5% CAGR vs -34.4%).
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".
MED vs OPK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $75.1M | $148.5M |
| Net Profit | — | $-31.3M |
| Gross Margin | 69.4% | 43.1% |
| Operating Margin | -10.4% | -25.8% |
| Net Margin | — | -21.1% |
| Revenue YoY | -36.9% | -19.2% |
| Net Profit YoY | — | -322.8% |
| EPS (diluted) | $-1.64 | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.1M | $148.5M | ||
| Q3 25 | $89.4M | $151.7M | ||
| Q2 25 | $105.6M | $156.8M | ||
| Q1 25 | $115.7M | $150.0M | ||
| Q4 24 | $119.0M | $183.6M | ||
| Q3 24 | $140.2M | $173.6M | ||
| Q2 24 | $168.6M | $182.2M | ||
| Q1 24 | $174.7M | $173.7M |
| Q4 25 | — | $-31.3M | ||
| Q3 25 | $-2.3M | $21.6M | ||
| Q2 25 | $2.5M | $-148.4M | ||
| Q1 25 | $-772.0K | $-67.6M | ||
| Q4 24 | — | $14.0M | ||
| Q3 24 | $1.1M | $24.9M | ||
| Q2 24 | $-8.2M | $-10.3M | ||
| Q1 24 | $8.3M | $-81.8M |
| Q4 25 | 69.4% | 43.1% | ||
| Q3 25 | 69.5% | 32.9% | ||
| Q2 25 | 72.6% | 31.5% | ||
| Q1 25 | 72.8% | 28.4% | ||
| Q4 24 | 74.1% | 46.1% | ||
| Q3 24 | 75.4% | 23.1% | ||
| Q2 24 | 73.2% | 28.4% | ||
| Q1 24 | 72.8% | 24.2% |
| Q4 25 | -10.4% | -25.8% | ||
| Q3 25 | -4.6% | 31.7% | ||
| Q2 25 | -1.0% | -38.3% | ||
| Q1 25 | -1.1% | -44.8% | ||
| Q4 24 | 0.6% | -18.0% | ||
| Q3 24 | 1.5% | 8.2% | ||
| Q2 24 | -4.7% | -33.9% | ||
| Q1 24 | 4.5% | -41.2% |
| Q4 25 | — | -21.1% | ||
| Q3 25 | -2.5% | 14.3% | ||
| Q2 25 | 2.3% | -94.7% | ||
| Q1 25 | -0.7% | -45.1% | ||
| Q4 24 | — | 7.6% | ||
| Q3 24 | 0.8% | 14.3% | ||
| Q2 24 | -4.8% | -5.7% | ||
| Q1 24 | 4.8% | -47.1% |
| Q4 25 | $-1.64 | $-0.04 | ||
| Q3 25 | $-0.21 | $0.03 | ||
| Q2 25 | $0.22 | $-0.19 | ||
| Q1 25 | $-0.07 | $-0.10 | ||
| Q4 24 | $0.08 | $0.02 | ||
| Q3 24 | $0.10 | $0.03 | ||
| Q2 24 | $-0.75 | $-0.01 | ||
| Q1 24 | $0.76 | $-0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.3M | $364.4M |
| Total DebtLower is stronger | — | $344.0M |
| Stockholders' EquityBook value | $198.9M | $1.3B |
| Total Assets | $248.0M | $1.9B |
| Debt / EquityLower = less leverage | — | 0.27× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.3M | $364.4M | ||
| Q3 25 | $173.5M | $412.0M | ||
| Q2 25 | $162.7M | $267.3M | ||
| Q1 25 | $164.6M | $428.8M | ||
| Q4 24 | $162.3M | $426.6M | ||
| Q3 24 | $170.0M | $400.1M | ||
| Q2 24 | $163.5M | $40.6M | ||
| Q1 24 | $156.4M | $75.6M |
| Q4 25 | — | $344.0M | ||
| Q3 25 | — | $344.2M | ||
| Q2 25 | — | $343.3M | ||
| Q1 25 | — | $439.2M | ||
| Q4 24 | — | $437.2M | ||
| Q3 24 | — | $441.0M | ||
| Q2 24 | — | $201.9M | ||
| Q1 24 | — | $350.1M |
| Q4 25 | $198.9M | $1.3B | ||
| Q3 25 | $214.7M | $1.3B | ||
| Q2 25 | $216.0M | $1.3B | ||
| Q1 25 | $211.0M | $1.3B | ||
| Q4 24 | $210.1M | $1.4B | ||
| Q3 24 | $207.3M | $1.4B | ||
| Q2 24 | $205.3M | $1.4B | ||
| Q1 24 | $211.0M | $1.3B |
| Q4 25 | $248.0M | $1.9B | ||
| Q3 25 | $268.2M | $2.0B | ||
| Q2 25 | $269.3M | $2.0B | ||
| Q1 25 | $280.0M | $2.1B | ||
| Q4 24 | $284.2M | $2.2B | ||
| Q3 24 | $291.2M | $2.3B | ||
| Q2 24 | $293.5M | $2.0B | ||
| Q1 24 | $302.8M | $2.0B |
| Q4 25 | — | 0.27× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | 0.26× | ||
| Q1 25 | — | 0.33× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.31× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.28× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.3M | $-25.9M |
| Free Cash FlowOCF − Capex | $-6.6M | $-28.6M |
| FCF MarginFCF / Revenue | -8.8% | -19.3% |
| Capex IntensityCapex / Revenue | 1.8% | 1.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.2M | $-190.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.3M | $-25.9M | ||
| Q3 25 | $12.1M | $-34.6M | ||
| Q2 25 | $-3.4M | $-83.4M | ||
| Q1 25 | $3.4M | $-34.6M | ||
| Q4 24 | $-4.9M | $-44.4M | ||
| Q3 24 | $9.1M | $-77.1M | ||
| Q2 24 | $13.1M | $-26.4M | ||
| Q1 24 | $7.3M | $-35.6M |
| Q4 25 | $-6.6M | $-28.6M | ||
| Q3 25 | $10.8M | $-37.8M | ||
| Q2 25 | $-4.8M | $-86.7M | ||
| Q1 25 | $1.9M | $-37.7M | ||
| Q4 24 | $-7.2M | $-49.8M | ||
| Q3 24 | $7.7M | $-85.0M | ||
| Q2 24 | $11.1M | $-33.7M | ||
| Q1 24 | $5.4M | $-40.0M |
| Q4 25 | -8.8% | -19.3% | ||
| Q3 25 | 12.0% | -24.9% | ||
| Q2 25 | -4.5% | -55.3% | ||
| Q1 25 | 1.6% | -25.2% | ||
| Q4 24 | -6.1% | -27.1% | ||
| Q3 24 | 5.5% | -49.0% | ||
| Q2 24 | 6.6% | -18.5% | ||
| Q1 24 | 3.1% | -23.0% |
| Q4 25 | 1.8% | 1.8% | ||
| Q3 25 | 1.5% | 2.1% | ||
| Q2 25 | 1.3% | 2.1% | ||
| Q1 25 | 1.3% | 2.1% | ||
| Q4 24 | 1.9% | 2.9% | ||
| Q3 24 | 1.0% | 4.6% | ||
| Q2 24 | 1.1% | 4.0% | ||
| Q1 24 | 1.1% | 2.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | -1.60× | ||
| Q2 25 | -1.36× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -3.17× | ||
| Q3 24 | 8.04× | -3.10× | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MED
Segment breakdown not available.
OPK
| Services | $71.1M | 48% |
| Transfer Of Intellectual Property And Other | $33.7M | 23% |
| IE | $22.1M | 15% |
| Rayaldee | $8.8M | 6% |
| Barda Agreement | $6.8M | 5% |
| MX | $6.3M | 4% |
